Table 3.
Range | Italy | France and Switzerland | United Kingdom | United States | |
---|---|---|---|---|---|
Reference Source | Verdoni et al (Bergamo, Italy) | Belhadjer et al. (13 hospitals in Frances and 1 hospital in Switzerland) | Whittaker et al. (13 hospitals in the UK; includes the 8 patients from Riphagen et al.) | § - Cheung et al (Morgan Stanley Children's Hospital, New York); ¶ - Chiotos et al (CHOP, Philadelphia) and Waltuch et al (Mount Sinai, New York) | |
Mean (SD) | Median (IQR) | Median (IQR) | Median (IQR) | ||
WBC (x103/L) | <12 | 10.8 (6.1) | 16 (12 – 23) | 17 (12 – 22) | § - 14.0 (4 – 35.9) ¶ - 20.6 (11.1 – 35.7) |
Absolute lymphocyte count | >950 | 860 (40) | N/A | 800 (500 – 1500) | § - 1212.1 (115.5 – 6444.9) ¶ - 310 (262 – 412) |
Platelets (103/uL) | <150 | 130 (32) | N/A | 151 (104 – 210) | § - 237 (69 – 892) ¶ - 120 (96.5 – 166.25) |
Peak BNP (pg/mL) | <100 | N/A | 4256 (2340 – 6503) | N/A | § - N/A ¶ - 1411 (517 – 3068) |
Peak NT-pro BNP (pg/mL) | * | 1255 (929) | 41484 (35811 – 52475) | 788 (172 – 10548) | § - 15833 (631 – 59291) ¶ - N/A |
Peak Troponin (ng/mL) | ** | 1.0 (1.862) | 0.408 (0.258 – 0.679) | 0.045 (0.008 – 0.294) | § - 0.0568 (0.006 – 0.278) ¶ - 0.24 (0.0675 – 0.8775) |
CRP (mg/dL) | <0.9 | 25 (15.3) | 24.1 (15.0 – 31.1) | 22.9 (15.6 – 33.8) | § - 20.0 (1.7 – 30.0) ¶ - 26.7 (17.6 – 30.2) |
D-Dimer (ug/mL) | <0.5 | 3.798 (1.318) | 5.284 (4.069 – 9.095) | 3.578 (2.085 – 8.235) | § - 4 (0.9 – 11) ¶ - 4.46 (3.3 – 11.5) |
Pro-Calcitonin (ng/mL) | <2 | N/A | 36 (8 – 99) | N/A | § - 21.7 (0.8 – 127) ¶ - 16.0 (15.08 – 58.85) |
IL-6 (pg/mL) | <8.5 | 117.1 (137.4) | 135 (87 – 175) | N/A | § - 226.3 (3.1 – 315) ¶ - 330 (268 – 406.5) |
Ferritin (ng/mL) | <150 | 1176 (1032) | N/A | 610 (359 – 1280) | § - 647.9 (83 – 1828) ¶ - 973 (762 – 1188) |
CRP: C-reactive protein, IL: Interleukin, NT-proBNP: N-terminal pro hormone B-type natriuretic peptide, WBC: White blood cells.